期刊文献+

CD133、CD44和PSCA在肝癌组织中的表达及其意义 被引量:2

Expression and significance of several candidate markers of tumor stem cell in hepatocellular carcinoma
原文传递
导出
摘要 目的研究CD133、CD44和PSCA在肝癌组织、癌旁肝组织和肝癌细胞系中表达的特异性。方法采用免疫组化SP法检测CD133、CD44和PSCA在70例肝细胞癌(HCC)、50例肝内胆管细胞癌(ICC)组织及培养的HepG2细胞的表达。结果 CD133、CD44和PSCA在HCC组织中,阳性率分别为58.6%(41/70)、61.4%(43/70)和40%(28/70);在ICC组织中的阳性率分别为56%(28/50)、52%(26/50)和44%(22/50);统计学分析显示三者在HCC和ICC的阳性率差异不显著(χ2=0.824,P>0.05);但PSCA在ICC的阳性表达强度明显高于HCC(P<0.05)。CD133、CD44、PSCA阳性细胞在HCC、ICC和HepG2培养细胞中的分布均存在散在和成簇/片状两种形式,其中CD133以散在分布为主,而CD44和PSCA则多呈成簇/片状分布。在HCC和ICC癌的旁组织中,CD133、CD44和PSCA阳性表达率分别为51.4%(36/70)、47.1%(33/70)和32.9%(23/70)以及46%(23/50)、32%(16/50)和36%(18/50),比较3种蛋白在HCC和ICC的癌旁组织中的阳性率无明显差异(P>0.05)。CD133、CD44、PSCA在HCC、ICC及其癌旁组织中的阳性表达有明显的一致性。结论 CD133、CD44和PSCA可能均是肝癌干细胞的特异性表面标记物,其中CD133的特异性最强;而PSCA可能是ICC较为特异的癌干细胞表面标记物。 Objective To study the specificity of expression of CD133,C144 and PSCA in liver cancer,pericarcinomatous liver tissues and HepG2 cells.Methods The immunohistochemistry was used to detect the expression of CD133,CD44 and PSCA in 70 hepatocellular carcinomas (HCC),50 intrahepatic cholangiocarcinomas (ICC) and HepG2 cells.Results In the-HCCs,the positive rates of CD133,CD44,PSCA were 58.6% (41/70),61.4% (43/ 70),40% (28/70).In the ICCs,the positive rates were 56% (28/50),52% (26/50),44% (22/50),respectively.The positive expression rates of CD133,CD44 and PSCA had no significant difference in HCCs and ICCs (x2 =0.824,P > 0.05),but the intensity of positive expression of PSCA in the ICCs was significantly higher than in HCCs (P < 0.05).The distributions of CD133,CD44,PSCA-positive cells in HCC,ICC and HepG2 cells existed two forms:scattered and clusters/flaky,and the scattered was the main distribution of CD133,while the CD44 and PSCA-positive cells were mainly distributed in clusters/flaky.The positive expression rates of CD133,CD44 and PSCA were 51.4% (36/70),47.1% (33/70),32.9% (23/70) and 46% (23/50),32% (16/50),36% (18/50) in the tissues surrounding HCC and ICC respectively,and the significant difference was not found (P > 0.05) for the expression rates of three kinds of proteins in the tissues nearby HCC and ICC.They for the expression of CD133,CD44,PSCA in the HCC,ICC were obviously consistency in their pericarcinomatous liver tissues.Conclusions CD133,CD44,PSCA might be specific markers of liver carcinoma stem cells,and CD133 might be the most specific surface marker of liver carcinoma stem cells,while PSCA might be the more specific surface markers for ICC.
作者 杨军 冯德云
出处 《诊断病理学杂志》 CSCD 北大核心 2014年第10期640-643,646,共5页 Chinese Journal of Diagnostic Pathology
关键词 肝癌 CD133 CD44 PSCA Liver carcinoma CD133 CD44 PSCA
  • 相关文献

参考文献20

  • 1Wu XZ,Zhao LS,Xu Q,et al.Differentiation of bone marrow mesenchymal stem cell into hepatocytes in hepatectomized mouse[J].J Biomed Eng,2005,22(6):1234-1237.
  • 2颜政,方驰华,高鹏.人原发肝细胞癌干细胞表面标志的初步研究[J].南方医科大学学报,2006,26(9):1304-1306. 被引量:18
  • 3张秋菊,刘斌,邢传平,苏勤军,董亮,钱震,高自芳.结直肠癌组织中ESA和CD44的表达及其临床病理意义[J].世界华人消化杂志,2009,17(14):1417-1421. 被引量:11
  • 4Shmelkov SV,St Clair R Lyden D,et al.AC133/CD133/Prominin-1[J].Int J Biochem Cell Biol,2005,37 (4):715-719.
  • 5Hughes EN,Colombatti A,August JT.Murine cell surface glycoprotein[J].J Biol Chem,1983,258(2):1014-1021.
  • 6Herrlich P,Z(o)ller M,Pals ST,et al.CD44 splice variants:metastases meets lymphocytes[J].Immunol Today,1993,14(8):395-399.
  • 7Tran CP,Lin C,Yamashiro J,et al.Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells[J].Mol Cancer Res,2002,1 (2):113-121.
  • 8Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63 (18):5821-5828.
  • 9Kim CF,Jackson EL Woolfenden AE.Identification of bronchioalveolar stem cells in normal lung and lung cancer[J].Cell,2005,121 (6):823-835.
  • 10Colins AT,Berry PA,Hyde C,et al.Prospective identification of tumorigenic prostate cancer stem cells[J].Cancer Res,2005,65(23):10946-10951.

二级参考文献27

  • 1Ishida T. Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma. Surg Today 2000; 30:28-32.
  • 2Gao AC, Lou W, Dong JT, Isaacs JT. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997; 57:846-849.
  • 3Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 1994; 125:437-446.
  • 4Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96:417-423.
  • 5Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Kochli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 2004; 86: 207-213.
  • 6Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zoller M. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res 2005; 309:345-357.
  • 7Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 2007; 171:386-395.
  • 8Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, Hildebrand D, Moldenhauer G, Langbein L, Franke WW, Weitz J, Zoller M. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007; 5:553-567.
  • 9Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007; 104: 10158-10163.
  • 10Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G, Baeuerle PA. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006; 94:128-135.

共引文献30

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部